| Autor: |
Senman B; Division of Cardiology Duke University Durham NC USA., Jentzer JC; Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA., Barnett CF; Division of Cardiology, Department of Medicine University of California San Francisco San Francisco CA USA., Bartos JA; Department of Medicine-Cardiovascular Division University of Minnesota Minneapolis MN USA., Berg DD; Division of Cardiovascular Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA USA., Chih S; Ottawa Heart Institute Ottawa Ontario Canada., Drakos SG; Department of Medicine, Division of Cardiovascular Medicine and Nora Eccles Harrison Cardiovascular Research and Training Institute University of Utah School of Medicine Salt Lake City UT USA., Dudzinski DM; Department of Cardiology Massachusetts General Hospital Boston MA USA., Elliott A; Department of Medicine-Cardiovascular Division University of Minnesota Minneapolis MN USA., Gage A; Department of Cardiovascular Medicine Centennial Medical Center Nashville TN USA., Horowitz JM; Division of Cardiology New York University Grossman School of Medicine New York NY USA., Miller PE; Section of Cardiovascular Medicine, Yale School of Medicine New Haven CT USA., Sinha SS; Inova Schar Heart and Vascular, Inova Fairfax Medical Campus Falls Church VA USA., Tehrani BN; Inova Schar Heart and Vascular, Inova Fairfax Medical Campus Falls Church VA USA., Yuriditsky E; Division of Cardiology New York University Grossman School of Medicine New York NY USA., Vallabhajosyula S; Division of Cardiology, Department of Medicine Warren Alpert Medical School of Brown University and Lifespan Cardiovascular Institute Providence RI USA., Katz JN; Division of Cardiology NYU Grossman School of Medicine & Bellevue Hospital Center New York NY USA. |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of the American Heart Association [J Am Heart Assoc] 2024 Mar 19; Vol. 13 (6), pp. e031979. Date of Electronic Publication: 2024 Mar 08. |
| DOI: |
10.1161/JAHA.123.031979 |
| Abstrakt: |
Cardiogenic shock continues to carry a high mortality rate despite contemporary care, with no breakthrough therapies shown to improve survival over the past few decades. It is a time-sensitive condition that commonly results in cardiovascular complications and multisystem organ failure, necessitating multidisciplinary expertise. Managing patients with cardiogenic shock remains challenging even in well-resourced settings, and an important subgroup of patients may require cardiac replacement therapy. As a result, the idea of leveraging the collective cognitive and procedural proficiencies of multiple providers in a collaborative, team-based approach to care (the "shock team") has been advocated by professional societies and implemented at select high-volume clinical centers. A slowly maturing evidence base has suggested that cardiogenic shock teams may improve patient outcomes. Although several registries exist that are beginning to inform care, particularly around therapeutic strategies of pharmacologic and mechanical circulatory support, none of these are currently focused on the shock team approach, multispecialty partnership, education, or process improvement. We propose the creation of a Cardiogenic Shock Team Collaborative-akin to the successful Pulmonary Embolism Response Team Consortium-with a goal to promote sharing of care protocols, education of stakeholders, and discovery of how process and performance may influence patient outcomes, quality, resource consumption, and costs of care. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Plný text